SCHEMBL31067446

SCHEMBL31067446

O=C(O)c1cc(C(F)(F)F)nn1-c1ccc2cc(Cl)ccc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 3/20 0.55
F10 P00742 6/20 0.55
PTGS2 P35354 5/20 0.49
PTGS1 P23219 4/20 0.49
GRN P28799 1/20 0.46
SORT1 Q99523 1/20 0.46
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44
THPO P40225 1/20 0.44
BLM P54132 1/20 0.44
PMP22 Q01453 1/20 0.44
HIF1A Q16665 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ORAI1 Q96D31 1/20 0.44
PDPK1 O15530 1/20 0.43
TRPV1 Q8NER1 1/20 0.43
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6769698 1.00 KLKB1 (0.55) KLKB1F10PTGS2PTGS1GRN
SCHEMBL18604629 0.88 PTGS2 (0.58) KLKB1PTGS2PTGS1GRNSORT1
SCHEMBL5584120 0.85 KLKB1 (0.69) KLKB1GRNSORT1TRPV1MEN1
SCHEMBL6763739 0.80 F10 (0.61) F10
SCHEMBL3224886 0.79 HTT (0.50) KLKB1PTGS2PTGS1GRNSORT1
SCHEMBL21462630 0.78 KLKB1 (0.59) KLKB1PTGS2PTGS1GRNSORT1
SCHEMBL950904 0.78 GRN (0.72) KLKB1PTGS2PTGS1GRNSORT1
SCHEMBL30677091 0.77 KLKB1 (0.57) KLKB1PTGS2PTGS1GRNSORT1
SCHEMBL18218817 0.77 GRN (0.62) KLKB1PTGS2PTGS1GRNSORT1
SCHEMBL1096199 0.76 PTGS2 (0.61) KLKB1F10PTGS2PTGS1GRN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4663636-A2 TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS BioCryst Pharmaceuticals, Inc. (US) 2025-12-17 EP disclosed
CN-113307772-B Human plasma kallikrein inhibitors 拜奥克里斯特制药公司 2024-06-28 CN disclosed